This page shows you the latest news items in this category. This is page number 12.

Total 73903 results found since Jan 2013.

Trump Administration Won’t Join Global Effort For COVID-19 Vaccine
The White House says it does not want to be constrained by multilateral groups like the World Health Organization.
Source: Science - The Huffington Post - September 1, 2020 Category: Science Source Type: news

Three ways the pharmaceutical industry can positively impact health equity
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today ’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view. Today, we are pleased to welcome a guest post from Dr. Charlotte Jones-Burton, Vice-President, Global Clinical Development, Nephrology, Otsuka Pharmaceutical Development& Commercialization, Inc. who is dedicated to creating healthier communities globally through drug development, patient advocacy and...
Source: The Catalyst - September 1, 2020 Category: Pharmaceuticals Authors: Guest Contributor Tags: PhRMA Member Company Health Equity Source Type: news

Guest Post: Amgen Foundation stands for equal opportunities in STEM learning
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today ’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view. Today, we are pleased to welcome a guest post from Eduardo Cetlin, President, Amgen Foundation on the work to bring mor e STEM opportunities to young people as well as advancing racial equity in STEM education.
Source: The Catalyst - August 24, 2020 Category: Pharmaceuticals Authors: Guest Contributor Tags: STEM Health Equity Source Type: news

Guest Post: Pride started with protest: Combatting the dual pandemics of COVID-19 and racism this Pride Month
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today ’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view. Today, we are pleased to welcome a guest post from Jay Brown, Human Rights Campaign Foundation's Senior Vice President of Programs, Research and Training on the importance of recognizing Pride Month and the fight for equality for all.
Source: The Catalyst - June 30, 2020 Category: Pharmaceuticals Authors: Guest Contributor Tags: Coronavirus Health Equity Source Type: news

Guest Post: Takeda seeks ‘new normal’ for cancer research during the COVID-19 pandemic
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today ’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view. Today, we are pleased to welcome a guest post from Chris Arendt, Ph.D., a leader of Takeda’s oncology team to discuss how the company is ensuring cancer research and medicines continue to benefit patients in the age of COVID-19.“The new normal” has been used to describe the challenging and dynamic circumstan...
Source: The Catalyst - June 24, 2020 Category: Pharmaceuticals Authors: Guest Contributor Tags: PhRMA Member Company Cancer Coronavirus Source Type: news

Guest post: A post-pandemic crisis: The mental toll on America
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today ’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view. Today, we are pleased to welcome a guest post from Reza Moghadam, PharmD, MBA, senior director, Population Health& Remote Customer Engagement with Otsuka Pharmaceuticals on the impact of mental health during COVID-19.
Source: The Catalyst - June 16, 2020 Category: Pharmaceuticals Authors: Guest Contributor Tags: Mental Health Coronavirus Source Type: news

Guest Post: From lab to jab: Vaccine development to prevent COVID-19
Conversations and healthy debate about issues facingour industry and the health care system are critical to addressing some of today ’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view. Today, we are pleased to welcome a guest post from Abby Bownas, manager, Adult Vaccine Access Coalition to discuss the importance of COVID-19 vaccine development.The emergence of a novel coronavirus in December 2019 took much of the world by surprise and its rapid spread forced many of us to drastically change the ...
Source: The Catalyst - June 11, 2020 Category: Pharmaceuticals Authors: Guest Contributor Tags: Research and Development Vaccines Coronavirus Source Type: news

Guest Post: Honoring Asian and Pacific Islander heritage in the age of COVID-19
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today ’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view. Today, we are pleased to welcome a guest post Juliet K. Choi, executive vice president and chief of staff of the Asian& Pacific Islander American Health Forum (APIAHF), a national health justice organization which influences policy, mobilizes communities, and strengthens programs and organizations to improve t...
Source: The Catalyst - May 29, 2020 Category: Pharmaceuticals Authors: Guest Contributor Tags: Coronavirus Source Type: news

Guest Post: What will we learn from COVID-19?
Conversations and healthy debate about issues facing our industry and the health care systemare critical to addressing some of today ’s challenges and opportunities. The Catalyst welcomesguest contributors, including patients, stakeholders, innovators and others, to share theirperspectives and point of view. Today, we are pleased to welcome a guest post from AlexanderHardy, chief executive officer, Genentech, A Member of the Roche Group.
Source: The Catalyst - May 27, 2020 Category: Pharmaceuticals Authors: Guest Contributor Tags: Research and Development PhRMA Member Company Coronavirus Source Type: news

Guest Post: Preserving clinical research sites during the coronavirus pandemic
Conversations and healthy debate about issues facing our industry and the healthcare system are critical to addressing some of today ’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view.
Source: The Catalyst - April 29, 2020 Category: Pharmaceuticals Authors: Guest Contributor Tags: Research and Development Clinical Trials Coronavirus Source Type: news

Guest post: Securing the health care supply chain during COVID-19
Conversations and healthy debate about issues facing our industry and the healthcare system are critical to addressing some of today ’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view.
Source: The Catalyst - April 14, 2020 Category: Pharmaceuticals Authors: Guest Contributor Tags: Coronavirus Source Type: news

Guest post: Looking out for the invisibly vulnerable in the time of COVID-19
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today ’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view.
Source: The Catalyst - March 26, 2020 Category: Pharmaceuticals Authors: Guest Contributor Tags: Research and Development PhRMA Member Company Mental Illness Infectious Diseases Coronavirus Source Type: news

Guest post: Takeda ’s efforts to address COVID-19
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today ’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view.
Source: The Catalyst - March 19, 2020 Category: Pharmaceuticals Authors: Guest Contributor Tags: Research and Development PhRMA Member Company Infectious Diseases Coronavirus Source Type: news

Guest post: H.R.3 is the wrong approach to help patients like me
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today ’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view. Views represented here may not be those of PhRMA, though they are no less key to a healthy dialogue on issues in health care today.
Source: The Catalyst - November 26, 2019 Category: Pharmaceuticals Authors: Guest Contributor Tags: diabetes chronic disease Voters for Cures Pelosi Plan Source Type: news

Guest post: Value-based agreements can improve outcomes and even save patients money at the pharmacy counter
Source: The Catalyst - November 7, 2019 Category: Pharmaceuticals Authors: Guest Contributor Tags: Value-Driven Health Care The Value Collaborative Source Type: news

Guest post: Sharing discounts and rebates is the right thing to do
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today ’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view. Views represented here may not be those of PhRMA, though they are no less key to a healthy dialogue on issues in health care today.
Source: The Catalyst - October 21, 2019 Category: Pharmaceuticals Authors: Guest Contributor Tags: diabetes Out of Pocket Costs Voters for Cures Source Type: news

Guest Post: Following my stroke, having access to ground-breaking medical innovation has never been more important
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today ’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view. Views represented here may not be those of PhRMA, though they are no less key to a healthy dialogue on issues in health care today.
Source: The Catalyst - September 4, 2019 Category: Pharmaceuticals Authors: Guest Contributor Tags: IPI Source Type: news

Guest Post: Using the patient voice to go boldly
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today ’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view. Views represented here may not be those of PhRMA, though they are no less key to a healthy dialogue on issues in health care today.
Source: The Catalyst - May 30, 2019 Category: Pharmaceuticals Authors: Guest Contributor Tags: Research and Development FDA Lupus Source Type: news

Guest Post: The importance of women, diversity and inclusion in STEM
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today ’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view. Views represented here may not be those of PhRMA, though they are no less key to a healthy dialogue on issues in health care today.
Source: The Catalyst - May 8, 2019 Category: Pharmaceuticals Authors: Guest Contributor Tags: STEM Source Type: news

Guest post: Hearing from patients on Rare Disease Day
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today ’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view. Views represented here may not be those of PhRMA, though they are no less key to a healthy dialogue on issues in health care today. In honor of Rare Disease Day, we sat down with Paul Melmeyer of the National Organization for Rare Disorders (NORD) to discuss rare diseases, how we can spur innovation and what can w...
Source: The Catalyst - February 28, 2019 Category: Pharmaceuticals Authors: Guest Contributor Tags: Rare Diseases FDA Source Type: news

Guest post: Copay accumulator adjustment programs lead to four times higher treatment discontinuation for patients with high deductibles
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today ’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view. Views represented here may not be those of PhRMA, though they are no less key to a healthy dialogue on issues in health care today.
Source: The Catalyst - February 21, 2019 Category: Pharmaceuticals Authors: Guest Contributor Tags: out of pocket costs Let's Talk About Cost Source Type: news

Guest post: Developing new payment models to ensure patients have access to high-investment therapies
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today ’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view. Views represented here may not be those of PhRMA, though they are no less key to a healthy dialogue on issues in health care today.
Source: The Catalyst - September 6, 2018 Category: Pharmaceuticals Authors: Guest Contributor Tags: Value-Driven Health Care The Value Collaborative Source Type: news

Guest post: Excellent care for LGBTQ patients requires cultural humility and specific medical knowledge
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today ’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view.In honor of LGBT Pride Month, we are pleased to share a blog post from Andrew Petroll, MD, MS is Associate Professor of Medicine (Division of Infectious Diseases) at the Medical College of Wisconsin (MCW).Views represented here are those of the authors and may not reflect those of PhRMA.
Source: The Catalyst - June 28, 2018 Category: Pharmaceuticals Authors: Guest Contributor Tags: Access HIV/AIDS Source Type: news

Guest post: Ensuring communities have a seat at the table: The importance of diversity in clinical trials
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today ’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view.
Source: The Catalyst - May 25, 2018 Category: Pharmaceuticals Authors: Guest Contributor Tags: Clinical Trials Source Type: news

Guest post: Advancing healthy hearts for patients
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today ’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view. Views represented here may not be those of PhRMA, though they are no less key to a healthy dialogue on issues in health care today.We are pleased to share a blog post from Dr. Keith C. Ferdinand, former board chair of the Association of Black Cardiologists.
Source: The Catalyst - February 28, 2018 Category: Pharmaceuticals Authors: Guest Contributor Tags: Medicines in Development Source Type: news

Guest Post: Driving towards a healthy heart
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today ’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view. Views represented here may not be those of PhRMA, though they are no less key to a healthy dialogue on issues in health care today.We are pleased to share a blog post from Dr. Robert Carr, president of the American College of Preventive Medicine.
Source: The Catalyst - February 8, 2018 Category: Pharmaceuticals Authors: Guest Contributor Tags: Prevention Source Type: news

Guest post: Help celebrate #ChampionsofScience: Nominate a pioneering researcher for the 2018 Dr. Paul Janssen Award for Biomedical Research
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today ’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view. Views represented here may not be those of PhRMA, though they are no less key to a healthy dialogue on issues in health care today.
Source: The Catalyst - January 29, 2018 Category: Pharmaceuticals Authors: Guest Contributor Tags: Research and Development PhRMA Member Company Source Type: news

Guest Post: Film chronicles clinical trials ‘paying it forward’
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today ’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view. Views represented here may not be those of PhRMA, though they are no less key to a healthy dialogue on issues in health care today.We are pleased to share a blog post from The Alliance for Aging Research.
Source: The Catalyst - November 28, 2017 Category: Pharmaceuticals Authors: Guest Contributor Tags: Clinical Trials Source Type: news

Guest Post: Policy conditions make or break leaders in biopharmaceutical innovation: Preliminary results from the 2017 BCI Survey
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today ’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view. Views represented here may not be those of PhRMA, though they are no less key to a healthy dialogue on issues in health care today.We are pleased to share a blog post from Professor Meir Pugatch, IPKM Professor of Valorisation, Entrepreneurship and Management at the University of Maastricht and Managing Direc...
Source: The Catalyst - July 24, 2017 Category: Pharmaceuticals Authors: Guest Contributor Tags: Economic Impact Intellectual Property Policy Solutions Source Type: news

What Mother's Day Feels Like During Infertility
This article was originally published on the Seleni Institute website and is reprinted here with permission. Seleni is a nonprofit mental health and wellness center providing clinical services, provider training, research funding and online information and support for women and mothers. You can follow Pamela Mahoney Tsigdinos on Twitter @PamelaJeane and Seleni @selenidotorg. -- This feed and its contents are the property of The Huffington Post, and use is subject to our terms. It may be used for personal consumption, but may not be distributed on a website.
Source: Healthy Living - The Huffington Post - May 10, 2017 Category: Consumer Health News Source Type: news

Guest Post: The Clinical trial experience from a patient & researcher perspective
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today ’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view. Views represented here may not be those of PhRMA, though they are no less key to a healthy dialogue on issues in health care today.
Source: The Catalyst - May 5, 2017 Category: Pharmaceuticals Authors: Guest Contributor Tags: Clinical Trials Source Type: news

Guest Post: Patients as research partners - Rethinking patient access to clinical trial data
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today ’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view. Views represented here may not be those of PhRMA, though they are no less key to a healthy dialogue on issues in health care today.We are pleased to share a blog post from Janssen ’s Andreas Koester, M.D., Ph.D., Vice President, Innovation, Janssen Research& Development Operations.
Source: The Catalyst - May 4, 2017 Category: Pharmaceuticals Authors: Guest Contributor Tags: Clinical Trials Source Type: news

Guest Post: Spotlighting the heroes in clinical trials
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today ’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view. Views represented here may not be those of PhRMA, though they are no less key to a healthy dialogue on issues in health care today.We are pleased to share a blog post from Eli Lilly and Company in celebration of Clinical Trials Awareness Week. The post was originally featured atLillyPad.
Source: The Catalyst - May 3, 2017 Category: Pharmaceuticals Authors: Guest Contributor Tags: Clinical Trials Source Type: news

Guest Post: Advancing oncology research through clinical trials
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today ’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view.Views represented here may not be those of PhRMA, though they are no less key to a healthy dialogue on issues in health care today.In celebration of Clinical Trials Awareness Week, we are pleased to share a blog postthat was written by Eric Rubin, M.D., medical oncologist and vice president, Global Clinical Oncolog...
Source: The Catalyst - May 2, 2017 Category: Pharmaceuticals Authors: Guest Contributor Tags: Clinical Trials Source Type: news

Guest Post: The importance of a modern FDA in drug discovery
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today ’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view. Views represented here may not be those of PhRMA, though they are no less key to a healthy dialogue on issues in health care today.We are pleased to share a blog post that was written by Jim Robinson, President, Astellas Americas, and originally published onThe Astellas Way.
Source: The Catalyst - March 22, 2017 Category: Pharmaceuticals Authors: Guest Contributor Tags: FDA PhRMA Member Company PDUFA FDA Modernization Source Type: news

Guest Post: Room for optimism in ALS research
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today ’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view. Views represented here may not be those of PhRMA, though they are no less key to a healthy dialogue on issues in health care today.
Source: The Catalyst - March 3, 2017 Category: Pharmaceuticals Authors: Guest Contributor Tags: Rare Diseases Source Type: news

Guest Post: Debra of America on Epidermolysis Bullosa
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today ’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view. Views represented here may not be those of PhRMA, though they are no less key to a healthy dialogue on issues in health care today.We are pleased to host a Q&A with Brett Kopelan, executive director for Debra of America.
Source: The Catalyst - March 3, 2017 Category: Pharmaceuticals Authors: Guest Contributor Tags: Rare Diseases Source Type: news

Guest Post: A Cure for Ellie on Leukodystrophy-LBSL
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today ’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view. Views represented here may not be those of PhRMA, though they are no less key to a healthy dialogue on issues in health care today.We are pleased to host a Q&A with Beth McGinn, operator of “A Cure for Ellie,” a non-profit foundation named for her eight-year old daughter. A Cure for Ellie supports cut...
Source: The Catalyst - March 2, 2017 Category: Pharmaceuticals Authors: Guest Contributor Tags: Rare Diseases Source Type: news

Guest Post: Epilepsy Foundation on rare diseases
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today ’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view. Views represented here may not be those of PhRMA, though they are no less key to a healthy dialogue on issues in health care today.We are pleased to host a Q&A with Angela Ostrom, chief legal officer& vice President public policy for the Epilepsy Foundation.
Source: The Catalyst - March 1, 2017 Category: Pharmaceuticals Authors: Guest Contributor Tags: Rare Diseases Source Type: news

Guest Post: Johnson and Johnson is celebrating outstanding scientists: Who will be next?
As a health care company with the mission of bringing forward transformational solutions for patients and consumers, innovative scientific advances are the essence of our success. We believe that a great idea can come from anywhere, and we are proud to fuel and support innovators all over the world.One way in which Johnson& Johnson supports and celebrates the role of scientists in advancing human health is theDr. Paul Janssen Award for Biomedical Research. This award honors the legacy of Dr. Paul Janssen, a gifted scientist and luminary in the pharmaceutical industry. Anyone who works in this industry knows what a feat...
Source: The Catalyst - February 15, 2017 Category: Pharmaceuticals Authors: Guest Contributor Tags: member companies Source Type: news

What No One Tells You About Medicare Coverage — Phyllis (Vol. 3)
The following is an excerpt from Phillip Moeller’s Get What’s Yours For Medicare: Maximize Your Coverage, Minimize Your Costs, out now on Simon & Schuster. This is the final installment of a three-part series on Medicare coverage. Let this story be your cautionary guide for the more practical roadblocks that Medicare may erect. Phyllis is pretty much always the sharpest tack in the box. While she loved being a partner in a big corporate law firm, she finally retired from the firm when she turned 75. Like many sharp tacks, however, Phyllis was no match for Medicare. And when she explained her problems to me,...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - November 10, 2016 Category: Consumer Health News Authors: Health – CBS Boston Tags: CBS Small Business Pulse Guest Posts - National Health Only CBS Small Business – National Health Coverage Medicare Retirement Source Type: news

What No One Tells You About Medicare Coverage — Carol (Vol. 2)
The following is an excerpt from Phillip Moeller’s Get What’s Yours For Medicare: Maximize Your Coverage, Minimize Your Costs, out now on Simon & Schuster. This is the second of a three-part series on Medicare coverage. The Medicare rules say that private Medicare Advantage insurance plans must cover at least the same things that Original Medicare (Parts A and B) covers. Many people naturally assume this means the two approaches to Medicare are the same. Big mistake. Phillip Moeller (Photo courtesy of Simon & Schuster) Carol’s husband, Ernesto, had a Medicare Advantage plan in Texas, when he was di...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - October 24, 2016 Category: Consumer Health News Authors: Health – CBS Boston Tags: CBS Small Business Pulse Guest Posts - National Health Only CBS Small Business – National Health Coverage Medicare Pulse Guest Contributors Retirement Source Type: news

What No One Tells You About Medicare Coverage — Glen (Vol. 1)
The following is an excerpt from Phillip Moeller’s Get What’s Yours For Medicare: Maximize Your Coverage, Minimize Your Costs, out now on Simon & Schuster. This is the first of a three-part series on Medicare coverage. Glen didn’t retire until he turned 70 in 2010. He and his wife, Margie, were covered until then by his employer’s health plan. Glen read the annual Medicare & You guide put out by the Centers for Medicare & Medicaid Services (CMS). His clear understanding from the guide was that he had been automatically enrolled in Medicare since he turned 65. This was not true. Glen made a big ...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - October 18, 2016 Category: Consumer Health News Authors: Health – CBS Boston Tags: CBS Small Business Pulse Guest Posts - National Health Only CBS Small Business – National Health Coverage Medicare Pulse Guest Contributors Retirement Source Type: news

Guest Post: New bioethical Points to Consider on truthful and non-misleading product communication
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today ’s challenges and opportunities. The Catalyst welcomes guest discussions, including patients, stakeholders, innovators and others, to share their perspectives and point of view. Views represented here may not be those of PhRMA, though they are no less key to a healthy dialogue on issues in health care today. We are pleased to host a guest blog post fromAllen Waxman executive vice president at Eisai Inc., and chair of BIO ’s Board Standing Committee on Bioethics.
Source: The Catalyst - August 4, 2016 Category: Pharmaceuticals Authors: Guest Contributor Tags: communication with healthcare professionals Source Type: news

Guest Post: New threats could fundamentally alter innovation in drug manufacturing
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today ’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view. Views represented here may not be those of PhRMA, though they are no less key to a healthy dialogue on issues in health care today.We ’re pleased to host a guest blog from Robyn Boerstling, vice president, infrastructure, innovation and human resources policy, National Association of Manufacturers.
Source: The Catalyst - August 2, 2016 Category: Pharmaceuticals Authors: Guest Contributor Tags: Innovation IP clinical research Manufacturing Source Type: news

Who Paid You to Say That, Doc?
Guest post by Armando Alvarez. Armando is a 2nd year MD/MPH student at the University of Miami Miller School of Medicine. He is passionate about childhood obesity prevention and increasing the access to care through telemedicine and telehealth services. See more about Armando here. Who paid you to say that, doc? That question, that highly inappropriate question is what will get you the truth, if they answer it. Major medical associations have been drawing conclusions and taking stances for the general well being of patients, but who is paying for those stances? In September of 2015, the American Academy of Pediatrics (AAP...
Source: Science - The Huffington Post - March 10, 2016 Category: Science Source Type: news

What Losing 110 Pounds REALLY Looks Like
By Elna Baker ALL PHOTOGRAPHED BY JESSICA PETERSON. This week's guest post comes from Elna Baker, a writer and performer I've long admired. For years, she's shared her journey with weight, sexuality, faith, and family with true honesty and humor. She's one of the boldest, funniest storytellers out there and it is an honor to share her voice in this space. -- Kelsey Recently, for a romantic getaway, my boyfriend took me to the Esalen Institute in Big Sur. He pitched it as a "spa retreat." This could not have been further from the truth. Esalen is a "community experiment in mental health" where they do things like group...
Source: Healthy Living - The Huffington Post - July 22, 2015 Category: Consumer Health News Source Type: news

Guest post: Capturing Content for Distance Learning
This is a guest post written by Jon Anscher on behalf of the Northwest Regional Primary Care Association.  The NWRPCA received a Technology Improvement Award from the NN/LM PNR to purchase equipment for capturing sessions at the organization’s two annual conferences. Community Health Centers (CHCs) need a comprehensive learning environment with modularized learning components that are current, interactive, and engaging and our goal was to deliver a higher quality and broader access through online resources. In an age where technology is changing too fast for our infrastructure to keep up, it is essential that CHC wo...
Source: Dragonfly - June 13, 2014 Category: Databases & Libraries Authors: Mahria Lebow Tags: Funding News From NN/LM PNR Technology Source Type: news

Coming Out as Single-At-Heart: Guest Post by Psyngle
What happens when you come out as single-at-heart? That’s what Psyngle tells us in this guest post. read more
Source: Psychology Today Sex Center - October 29, 2013 Category: Sexual Medicine Authors: Bella DePaulo, Ph.D. Tags: Relationships Resilience Sex Social Life Asexual coming out as lesbian family friends gay pride ideology of marriage and family inappropriate questions LGBT living alone living apart together living arrangements needing your Source Type: news